EN
HI
Summary
As of 5 Oct, 2026, Fredun Pharmaceuticals stock price is ₹1355.2. During the trading session, the stock has moved between an intraday low of ₹1334.10 and an intraday high of ₹1407.30. Over the last 52 weeks, Fredun Pharmaceuticals has traded between ₹1195.20 and ₹1590.00.
The stock has recorded a trading volume of 38,880 shares,. Its Average Traded Price (ATP) is ₹1368.87, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 47 @ ₹1355.20.
Fredun Pharmaceuticals has an upper circuit limit of ₹1490.70 and a lower circuit limit of ₹1219.70. The total value traded stands at ₹5.32 CR, and the delivery percentage for the day is 49.36%.
The stock is currently traded with a market lot size of 1. Fredun Pharmaceuticals also offers a dividend yield of 0.02%.
Fredun Pharmaceuticals Share Price Chart
Fredun Pharmaceuticals Share Key Metrics
Volume
38880.00
Market Cap
2241.24 CR
LTQ@LTP
47@1355.20
ATP
1368.87
Var Margin
25.74 %
Circuit Range
1219.7-1490.7
Delivery %
49.36 %
Value
5.32 CR
ASM/GSM
No
Market Lot
1
Fredun Pharmaceuticals Fundamentals
P/E Ratio
52.18
P/B Ratio
7.51
Div. Yield
0.02
Sector P/E
42.73
Sector P/B
3.55
Sec. Div. Yield
0.52
Fredun Pharmaceuticals Resistance and Support
Pivot 1416.93
Resistance
First Resistance
1434.96
Second Resistance
1465.43
Third Resistance
1483.46
Support
First Support
1386.46
Second Support
1368.43
Third Support
1337.96
Fredun Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 01 2026 | 1404.5 | 1355.2 | -3.51% | 1407.3 | 1334.1 |
| Wed Sep 30 2026 | 1403 | 1404.5 | 0.87% | 1447.4 | 1398.9 |
| Tue Sep 29 2026 | 1393.8 | 1392.4 | 0.39% | 1424.9 | 1295 |
Fredun Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2025-09-25 | Preferential Issue of shares & Others |
| 2026-08-05 | Quarterly Results |
| 2026-05-25 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-07-30 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-04 | Quarterly Results |
| 2024-10-26 | Quarterly Results |
| 2024-10-03 | Others |
| 2024-07-29 | Quarterly Results |
Fredun Pharmaceuticals News
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Allotment
Fredun Pharmaceuticals has allotted 3,61,599 equity shares of Rs.10 face value to non-promoter allottees. This allotment is a result of the conversion of 1,20,533 warrants, with entitlements adjusted post a 1:2 bonus issue.
Sep 22 2026 19:05:22
Fredun Pharmaceuticals Ltd - 539730 - Revised Outcome Of Board Meeting Dated 16Th September, 2026
Fredun Pharmaceuticals' Board allotted 361,599 equity shares to non-promoter allottees. These shares resulted from the conversion of 120,533 warrants, with the conversion ratio adjusted after the company's 1:2 bonus issue.
Sep 22 2026 18:28:25
Read More
Fredun Pharmaceuticals Management
| Name | Position |
|---|---|
| Daisy Dsouza | Non Executive Independent Director |
| Sonal Desai | Non Executive Independent Director |
Fredun Pharmaceuticals Similar Stocks
Sakar Healthcare Ltd.
1075.00
-18.05 (1.65%)
Indoco Remedies Ltd.
251.75
-9.92 (3.79%)
Syncom Formulations (India) Ltd.
23.96
-1.12 (4.47%)
Dr Agarwals Eye Hospital Ltd.
5159.00
29.00 (0.57%)
Panacea Biotec Ltd.
359.05
-6.95 (1.90%)
Beta Drugs Ltd.
2073.30
20.30 (0.99%)
Venus Remedies Ltd.
0.00
0.00 (0.00%)
Windlas Biotech Ltd.
1082.40
-8.90 (0.82%)
Fredun Pharmaceuticals FAQs
The Buying Price of Fredun Pharmaceuticals share is 1355.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Fredun Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Fredun Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Fredun Pharmaceuticals shares is 52.18. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Fredun Pharmaceuticals shares is 7.51. Useful to assess the stock's value relative to its book value.
To assess Fredun Pharmaceuticals’s valuation compare Sector P/E, P/B which are 42.73 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Fredun Pharmaceuticals is 2241.24 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Fredun Pharmaceuticals share price is 1590.00 & 1195.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Fredun Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in FREDUN
